Cargando…
437 Novel Targeting of Semaphorin 7a-Mediated Survival Signaling in ER+ Breast Cancer to Mitigate Therapy Resistance
OBJECTIVES/GOALS: Estrogen receptor-positive (ER+) breast cancers (BC) comprise >70% of all BC and cause the most BC-related deaths in women worldwide. Despite available therapies against ER+ BC, recurrence often arises due to development of endocrine therapy resistance. Thus, our goal is to iden...
Autores principales: | Steinmetz, Rachel, Lyons, Traci |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129791/ http://dx.doi.org/10.1017/cts.2023.465 |
Ejemplares similares
-
Postpartum breast cancer progression is driven by semaphorin 7a mediated invasion and survival
por: Tarullo, Sarah E, et al.
Publicado: (2020) -
Anoikis resistance in mammary epithelial cells is mediated by semaphorin 7a
por: Rutherford, Taylor R., et al.
Publicado: (2021) -
Hormonal Regulation of Semaphorin 7a Promotes Therapeutic Resistance in Breast Cancer
por: Crump, Lyndsey, et al.
Publicado: (2021) -
66361 TL1 Team Approach to Predicting Response to Spinal Cord Stimulation for Chronic Low Back Pain
por: See, Kyle, et al.
Publicado: (2021) -
Semaphorin 7a exerts pleiotropic effects to promote breast tumor progression
por: Black, Sarah, et al.
Publicado: (2016)